Marina Saad

Dr. Marina Saad


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DRDejan Radovanovic
Dejan Radovanovic
MRMaurizio Rizzi
Maurizio Rizzi
SPStefano Pini
Stefano Pini
MSMarina Saad
Marina Saad
Davide ChiumelloDavide Chiumello
Davide Chiumello
PSPierachille Santus
Pierachille Santus
Since the beginning of March 2020, the coronavirus disease 2019 (COVID-19) pandemic has caused more than 13,000 deaths in Europe, almost 54% of which has occurred in Italy. The Italian healthcare system is experiencing a stressful burden, especially in terms of intensive care assistance. In fact, the main clinical manifestation of COVID-19 patients is represented by an acute hypoxic respiratory failure secondary to bilateral pulmonary infiltrates, that in many cases, results in an acute respiratory distress syndrome and requires an invasive ventilator support. A precocious respiratory support with non-invasive ventilation or high flow oxygen should be avoided to limit the droplets’ air-dispersion and the healthcare workers’ contamination. The application of a continuous positive airway pressure (CPAP) by means of a helmet can represent an effective alternative to recruit diseased alveolar units and improve hypoxemia. It can also limit the room contamination, improve comfort for the patients, and allow for better clinical assistance with long-term tolerability. However, the initiation of a CPAP is not free from pitfalls. It requires a careful titration and monitoring to avoid a delayed intubation. Here, we discuss the rationale and some important considerations about timing, criteria, and monitoring requirements for patients with COVID-19 respiratory failure requiring a CPAP treatment.

1 August 2019 in Pharmacological Research
Verified
Journal Article
Closed access
PSPierachille Santus
Pierachille Santus
MSMarina Saad
Marina Saad
Giovanni DamianiGiovanni Damiani
Giovanni Damiani
VPVincenzo Patella
Vincenzo Patella
DRDejan Radovanovic
Dejan Radovanovic

23 January 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
MSMarina Saad
Marina Saad
SPStefano Pini
Stefano Pini
DDDanzo Danzo
Danzo Danzo
FMFrancesca Mandurino Mirizzi
Francesca Mandurino Mirizzi
CACarmine Arena
Carmine Arena
PSPierachille Santus
Pierachille Santus
Acute respiratory failure (ARF) is a common life-threatening medical condition, with multiple underlying etiologies. In these cases, many factors related to systemic inflammation, prolonged use of steroids, and lung mechanical abnormalities (such as hyperinflation or increased elastic recoil due to pulmonary oedema or fibrosis) may act as synergic mechanisms leading to diaphragm dysfunction. The assessment of diaphragm function with ultrasound has been increasingly investigated in the emergency department and during hospital stay as a valuable tool for providing additional anatomical and functional information in many acute respiratory diseases. The diaphragmatic ultrasound is a noninvasive and repeatable bedside tool, has no contraindications, and allows the physician to rapidly assess the presence of diaphragmatic dysfunction; this evaluation may help in estimating the need for mechanical ventilation (and the risk of weaning failure), as well as the risk of longer hospital stay and higher mortality rate. This study presents an overview of the recent evidence regarding the evaluation of diaphragmatic function with bedside ultrasound and its clinical applications, including a discussion of real-life clinical cases.

Verified
Journal Article
Open access
PDF file
SNStefania Nicola
Stefania Nicola
RBRichard Borrelli
Richard Borrelli
IRIrene Ridolfi
Irene Ridolfi
VBVirginia Bernardi
Virginia Bernardi
PBPaolo Borrelli
Paolo Borrelli
LBLuisa Brussino
Luisa Brussino
Introduction: Asthma, along with inhaled steroids, was initially considered a risk factor for worse clinical outcomes in COVID-19. This was related to the higher morbidity observed in asthma patients during previous viral outbreaks. This retrospective study aimed at evaluating the prevalence of asthma among patients admitted due to SARS-CoV-2 infection as well as the impact of inhaled therapies on their outcomes. Furthermore, a comparison between patients with asthma, COPD and the general population was made. Methods: All COVID-19 inpatients were recruited between February and July 2020 from four large hospitals in Northwest Italy. Data concerning medical history, the Charlson Comorbidity Index (CCI) and the hospital stay, including length, drugs and COVID-19 complications (respiratory failure, lung involvement, and the need for respiratory support) were collected, as well as the type of discharge. Results: patients with asthma required high-flow oxygen therapy (33.3 vs. 14.3%, p = 0.001) and invasive mechanical ventilation (17.9 vs. 9.5%, p = 0.048) more frequently when compared to the general population, but no other difference was observed. Moreover, asthma patients were generally younger than patients with COPD (59.2 vs. 76.8 years, p < 0.001), they showed both a lower mortality rate (15.4 vs. 39.4%, p < 0.001) and a lower CCI (3.4 vs. 6.2, p < 0.001). Patients with asthma in regular therapy with ICS at home had significantly shorter hospital stay compared to those with no treatments (25.2 vs. 11.3 days, p = 0.024). Discussion: Our study showed that asthma is not associated with worse outcomes of COVID-19, despite the higher need for respiratory support compared with the general population, while the use of ICS allowed for a shorter hospital stay. In addition, the comparison of asthma with COPD patients confirmed the greater frailty of the latter, according to their multiple comorbidities.

5 September 2021 in European Respiratory Journal
Verified
Conference Paper
Closed access
MSMarina Saad
Marina Saad
EFElisa Franceschi
Elisa Franceschi
SPStefano Pini
Stefano Pini
GCGiuseppe Croce
Giuseppe Croce
LPLuca Perotto
Luca Perotto
PSPierachille Santus
Pierachille Santus
Background: Endothelial dysfunction is a consistent finding in most diabetic adults; its degree seems to be related to plasmatic and systemic nitric oxide (NO) levels and can be easily monitored measuring fractional exhaled nitric oxide (FENO). It is unknown if such anomalies are detectable at early stages of the disease, such as in children. Aims and objectives: To investigate airways’ inflammation in children with type 1 diabetes (T1D) as compared to age matched healthy controls. Methods: This was a pilot, interventional, physiological, controlled study conducted in the Respiratory Unit of L. Sacco Hospital in Milan, Italy, on 24 diabetic children (median age 13.3 years) and 20 healthy children (median age 12.8 years). Multi-flow FENO was assessed with a semi-portable off-line NO analyzer according to the ATS/ERS recommendations. FENO values higher than 15 ppb were considered a marker of airway inflammation and endothelial dysfunction [Buchvald, F. et al, J Allergy Clin Immunol 2005;115:1130-1136]. Results: Baseline FENO at 50 ml/s was higher in children with T1D compared with controls (median 16 IQR:12-22 vs 10 ppb IQR:7.5-13, p=0.0002). FENO was >15 ppb in 13 children with T1D and in one healthy control (p=0.0002). FENO was significantly higher in children with T1D at all the tested expiratory flows (i.e. 100 ml/s, 150 ml/, 300 ml/s). On univariate analysis, FENO at all expiratory flows correlated with the presence of diabetes (p<0.0001), but no significant correlations were found between FENO, gender, BMI and age. Conclusions: Diabetic children have higher FENO values compared to healthy matched controls, which might represent an early sign of endothelial dysfunction and lung damage in diabetic children.

5 September 2021 in European Respiratory Journal
Verified
Conference Paper
Closed access
MSMarina Saad
Marina Saad
SPStefano Pini
Stefano Pini
EFElisa Franceschi
Elisa Franceschi
CSChiara Di Simone
Chiara Di Simone
LPLuca Perotto
Luca Perotto
PSPierachille Santus
Pierachille Santus
Background: As opposed to adult patients with diabetes, limited information is available regarding impairment of exercise capacity in diabetic children. Aims and objectives: To investigate exercise capacity and efficiency in children with type 1 diabetes mellitus (T1D) as compared to age matched healthy controls. Methods: This was a pilot, interventional, physiological, controlled study conducted in the Respiratory Unit of L. Sacco Hospital in Milan, Italy, on 24 diabetic children (median age 13.3 years) and 20 healthy children (median age 12.8 years). Subjects performed plethysmography, lung diffusion capacity for carbon monoxide (DLCO) and cardio-pulmonary exercise test, measuring VO2 peak, VCO2, minute ventilation (VE) and respiratory exchange ratio (RER). Results: Children with T1D had a steeper %predicted VE/VCO2 slope (median (IQR) 109 (107.0-118.5) VS 100 (98-103.5); p<0.0001) and a reduced %predicted VO2 peak (67.3 (57.5-75.5) VS 78 (69.5-82); p=0.008) as compared to healthy controls. Younger age and presence of diabetes were independent predictors for VE/VCO2 slope at the multivariate analysis (diabetes, 95%CI: 3.4;21.7, p=0.009; age, 95%CI: -3.9;-0.6, p=0.009), and lower DLCO was significantly correlated with steeper VE/VCO2 slope (r=-0.47, p=0.001). Conclusions: Exercise capacity and ventilatory efficiency are reduced in diabetic children compared with healthy controls. Anatomical and biochemical remodeling and lung damage previously described in diabetic adults might already taking part in children with T1D.